Lactose (India) Limited engages in manufacturing and trading pharmaceutical products in India. The company offers lactose monohydrate, an excipient; and dry granulated, film, and lacquer coated tablets, as well as products in liquid dose forms. It also provides disaccharide lactulose, a bulk active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as a prebiotic; and galacto-oligosaccharides, a prebiotic that has application in dairy products, beverages, bakery products, infant and clinical nutrition, and geriatric nutrition, as well as in products for children or adolescents. The company also exports uncoated and blister packed solid dose forms, and other products to Russia, Kazakhstan, Belarus, Nigeria, Sri Lanka, and internationally. It has a strategic alliance with Kerry Group. Lactose (India) Limited was founded in 1991 and is headquartered in Mumbai, India.
lactose india ltd
(LACT:Bombay Stock Exchange)
Unit No. G - 02
'A' wing, Ground Floor
Navbharat Estates, Zakaria Bunder Road
Phone: 91 22 2411 7030
Fax: 91 22 2411 7034www.lactoseindialimited.com
|No competitor information is available for LACT.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact LACTOSE INDIA LTD, please visit www.lactoseindialimited.com. Company data is provided by Capital IQ. Please use this form to report any data issues.